IWLD iShares Core MSCI Wld Ex Aus ESG ETF
- 55.940
- -0.010-0.02%
Update: Truist Ups Price Target on NVIDIA to $145 From $140 on Improving Fundamentals, Reiterates Buy Rating
Jefferies Adjusts Price Target on Eli Lilly to $1,113 From $1,050
Craig-Hallum Maintains NVIDIA(NVDA.US) With Buy Rating
Morgan Stanley Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,106
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101
Eli Lilly Price Target Maintained With a $1106.00/Share by Morgan Stanley
A Quick Look at Today's Ratings for NVIDIA(NVDA.US), With a Forecast Between $145 to $175
Eli Lilly Analyst Ratings
Morgan Stanley Reiterates Overweight on Eli Lilly, Maintains $1106 Price Target
Truist Securities Maintains Buy on NVIDIA, Raises Price Target to $145
Wolfe Research Maintains Microsoft(MSFT.US) With Buy Rating, Cuts Target Price to $495
Truist Adjusts Price Target on NVIDIA to $145 From $140, Maintains Buy Rating
Nvidia Price Target Maintained With a $175.00/Share by Loop Capital
NVIDIA Analyst Ratings
Loop Capital Reiterates Buy on NVIDIA, Maintains $175 Price Target
Craig-Hallum Maintains NVIDIA(NVDA.US) With Buy Rating
Morgan Stanley Maintains NVIDIA(NVDA.US) With Buy Rating, Maintains Target Price $144
Loop Capital Maintains NVIDIA(NVDA.US) With Buy Rating, Maintains Target Price $175
Loop Capital Maintains Microsoft(MSFT.US) With Buy Rating, Maintains Target Price $500
Wells Fargo Maintains Microsoft(MSFT.US) With Buy Rating, Maintains Target Price $515